Previous 10 | Next 10 |
2024-06-12 14:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-05 11:21:33 ET More on iShares U.S. Medical Devices ETF: IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on iShares U....
InMode to Present at Jefferies Healthcare Conference PR Newswire YOKNEAM, Israel , May 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca , Chief Financial Off...
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand PR Newswire IRVINE, Calif. , May 8, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is the first aesthetic company to o...
2024-05-08 01:50:41 ET Summary InMode's growth has plummeted due to sales execution issues, manufacturing delays, reduced demand, and high interest rates. INMD's business seems heavily reliant on economic conditions, beyond management's control. Shareholders expressed frustrat...
2024-05-02 19:15:11 ET Image source: The Motley Fool. InMode (NASDAQ: INMD) Q1 2024 Earnings Call May 02, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: InMode (INMD) Q1 2024 Earnings Call Transcript
2024-05-02 14:04:10 ET InMode Ltd. (INMD) Q1 2024 Earnings Conference Call May 2, 2024 08:30 ET Company Participants Miri Seagal - Investor Relations Moshe Mizrahy - Chief Executive Officer Michael Kreindel - Co-Founder and Chief Technology Officer Yair Malca...
2024-05-02 07:05:15 ET More on InMode InMode: More Headwinds Than Expected, Wait For A Floor To Materialize (Rating Downgrade) InMode's Quest For Growth Amidst Aesthetic Adversities InMode Does Not Look Pretty Right Now: Time To Buy InMode Q1 2024 Earnings Pr...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M; PR Newswire Company Announces Share Repurchase Program of Up to 8.37 Millio...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...